Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+, Mozilla Firefox 20+, Internet Explorer 11, Opera 15–18, Apple Safari 7, SeaMonkey 2.15-2.23

Become a member
  1. OncologyPRO
  2. Meeting Resources
  3. ESMO Congress 2022

Bristol Myers Squibb - The Treatment Paradigm Shift: Unlocking New Chapters with I-O in Thoracic Cancers

Considering the Options: Survivorship in Metastatic NSCLC and Potential Approaches for I-O–Experienced Patients

Date

10 Sep 2022

Session

Bristol Myers Squibb - The Treatment Paradigm Shift: Unlocking New Chapters with I-O in Thoracic Cancers

Topics

Tumour Site

Non-Small Cell Lung Cancer;  Mesothelioma

Presenters

Virginie Westeel

Authors

V. Westeel

Author affiliations

  • CHRU Besancon - Hopital Jean Minjoz, 25030 - Besancon/FR

Resources

Login to get immediate access to this content.

If you do not have an ESMO account, please create one for free.

Login

Resources from the same session

Welcome and Introductions

Presenter: Virginie Westeel

Session: Bristol Myers Squibb - The Treatment Paradigm Shift: Unlocking New Chapters with I-O in Thoracic Cancers

Resources:

Webcast

Live Q&A and Closing Remarks

Presenter: Dean Fennell

Session: Bristol Myers Squibb - The Treatment Paradigm Shift: Unlocking New Chapters with I-O in Thoracic Cancers

Resources:

Webcast

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings

  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.